OPEN Co-Director

Professor of Medicine and Head of Addiction Medicine, OHSU

General internist, addiction medicine physician, and health services researcher. Todd’s NIH-funded work focuses on the integration of novel addiction treatment and prevention strategies in diverse settings. He is the co-chair of Oregon Psilocybin Advisory Board’s research subcommittee.

OPEN Co-Director

Assistant Scientist, Legacy Research Institute

Neuroscientist and multidisciplinary researcher specializing in cannabis, pain management, harm reduction, and substance use. Adie has served in numerous public service roles, advocating for sensible regulation, consumer education, and health equity.

OPEN Co-Founder

CEO of Portland Psychotherapy Clinic, Research, & Training Center

Scientist at the Portland Institute for Psychedelic Science where he is conducting clinical trials involving MDMA and psilocybin. He is an expert in applying Acceptance and Commitment Therapy (ACT) and psychedelic-assisted therapy to address shame and foster self-compassion.

Investigator

Associate Professor of Psychiatry, OHSU

Dual board-certified in Psychiatry and Addiction Medicine, and Director of the Social Neuroscience & Psychotherapy Lab housed at the Portland VA, where he conducts clinical trials of psilocybin and MDMA-assisted therapy. He is a member of the Oregon Psilocybin Advisory Board.

Investigator

Assistant Professor, Addiction Medicine Section, OHSU

Addiction medicine clinician and health services researcher. Focused on improving care for women, perinatal, and gender minority people with substance use disorders. Ximena is enrolled in the CIIS Psychedelic Therapies and Research Certificate Program (June 2025).

Investigator

Assistant Professor of Medicine, School of Medicine, OHSU

Epidemiologist and statistician with extensive experience studying the intersection of substance use, HIV, and mental health. He specializes in research design and analysis, and his projects focus on translation of findings from studies to “real world” clients and patients.

Research Coordinator

Clinical Research Project Manager, Addiction Medicine Section, OHSU

Kellie is engaged in an academic career in community partnered research and implementation of interventions to address health inequities and medical consequences of substance use disorders in diverse populations.

Research Analyst

Statistical analyst, Division of General Internal Medicine, OHSU

Devin’s diverse research encompasses substance use, hepatitis C, psychedelics, and social determinants of health. His contributions to OPEN’s research include data preparation, analyses, and table and figure development.

Senior Advisor

ResearchGate (19) Dennis Mccarty

Dennis works at the intersection of policy, practice, and research to improve the delivery of care for people with alcohol and drug use disorders. He has led many national research and drug treatment programs such as the Western States Node of the National Drug Abuse Clinical Trials Network.

Senior Advisor

Award-winning Professor of Epidemiology (NYU) and world-renown leader in the fields of AIDS and injection drug use. Consultant to the CDC, NIDA, the National Academy of Sciences, and the World Health Organization.